News

Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025

PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will…

11 months ago

Catheter Precision, Inc.  Announces The Closing of its Acquisition of PeriKard, LLC

FORT MILL, S.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device…

11 months ago

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04,…

11 months ago

Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

MIAMI, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

11 months ago

Allogene Therapeutics Announces Participation in February Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering…

11 months ago

TOMI Environmental Solutions Expands Deployment of SteraMist for California Wildfire Recovery

Company’s Decontamination Technology Addresses Airborne and Surface Contaminants in Fire-Damaged StructuresFREDERICK, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental…

11 months ago

Coloplast Finance B.V. – Interim Financial Report, Q1 2024/25

2024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an…

11 months ago

Blue Cross Blue Shield of Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine

Nearly three million members of the largest health insurance plan in Massachusetts are now eligible for reimbursement when prescribed with…

11 months ago

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

– Submission of Investigational New Drug Application (IND) to US FDA expected in 2025 – NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE)…

11 months ago

HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future

“Highlights 2024 Collaborative Partnerships and Product Development Designed to Spur Growth in 2025 and Beyond”NAPLES, Fla., Feb. 04, 2025 (GLOBE…

11 months ago